Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

LeMaitre Vascular Sees Q1 EPS $0.36-$0.41 vs $0.34 Est., Sales $50.5M-$52.9M vs $50.21M Est.; Sees FY24 EPS $1.60-$1.71 vs $1.53 Est., Sales $209.7M-$214.3M vs $209.99M Est.

Author: Benzinga Newsdesk | February 27, 2024 06:39pm

Posted In: LMAT